Pegcrisantaspase
Pegcrisantaspase Uses, Dosage, Side Effects, Food Interaction and all others data.
Pegcrisantaspase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).
| Trade Name | Pegcrisantaspase |
| Generic | Pegcrisantaspase |
| Pegcrisantaspase Other Names | Asparec, Mpeg-r-crisantaspase, Pegcrisantaspase, Pegylated dickeya chrysanthemi l-asparaginase, Pegylated erwinia chrysanthemi l-asparaginase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pegcrisantaspase
